The Everest Base Camp Climb to Fight Cancer


The Everest Base Camp Climb to Fight Cancer

Science is at a moment of tremendous possibility. By combining two of my passions — biotech journalism and the mountains — I hope to raise significant money and awareness for a first-rate scientific institution. Fred Hutch is among the leaders in cancer and infectious disease research.

Support Fred Hutch by joining me on a trek to Everest Base Camp (17,500 feet) and to the spectacular Himalayan vista on Kala Pattar (18,300 feet).

IMPORTANT NOTE: This trip will NOT involve any technical climbing. No mountaineering experience is necessary for the trek to Everest Base Camp (EBC). All you really need is a good pair of hiking boots, some warm layers, and a light backpack. There will be no travel through the Khumbu Icefall, the dangerous crevasse and avalanche zone. If you have hiked on trails at 14,000 feet in North America, you are ready for this trip of a lifetime.


The Idea:
Join a team of biotech leaders on this storied trail in the Himalayas. By joining this expedition, you will be doing three things.
• You will have an unforgettable life experience
• You’ll form meaningful relationships with peers
• You’ll contribute to a great cause

This expedition is modeled after the Kilimanjaro Climb of 2019. Recap 

Donate today to support the Climb to Fight Cancer at Fred Hutch!


Donations go to:

Pheriche Sponsor

Namche Sponsor

Lukla sponsors:


Guide Service:

Everest Base Camp trek

About Luke Timmerman

Who am I?
Luke Timmerman is a biotech journalist, author, and entrepreneur. I’m the founder of Timmerman Report, a biotech newsletter, and author of “Hood: Trailblazer of the Genomics Age.” My Climb to Fight Cancer campaigns on Mt. Everest and Kilimanjaro have raised $2.3 million for cancer research at Fred Hutch since 2017.

Why an Everest Base Camp trek?
The scenery is spectacular. The cultural experience in Nepal is life-changing.

I hiked these trails to Base Camp at the beginning of my expedition to the summit of Mt. Everest on May 22, 2018. The summit is at 29,031 feet of elevation. This group will not set foot on the highest flanks of the mountain, but it will require dedication to hike to Base Camp at 17,500 feet.

Your journey to get an up-close look at the world’s highest mountain is symbolic of the ambitions and dedication of this fundraising campaign. It offers hope to cancer patients.

This trek is accessible. It doesn’t require climbing experience. People in good physical shape can do it. A trek to Everest Base Camp poses none of the hazards of the summit of Mt. Everest.

Along the way, you will also have a chance to experience Tibetan Buddhism up close.

This is the trip of a lifetime.

Team Details

Who’s On The Team?

Who’s Guiding?


That’s me with senior guides Lakpa Rita Sherpa and Eric Murphy of Alpine Ascents International. Kilimanjaro expedition, July 2019.

Eric Murphy will be the lead guide for our trek to EBC. Eric was one of the guides on my successful Everest summit expedition in 2018. He was the lead guide on Kilimanjaro in 2019. He’s outstanding.

Beyond Eric, we will be supported by the crew at Alpine Ascents International. Seattle-based AAI has 30 years of experience in Nepal. AAI has trusting long-term relationships with the Sherpa who live in the villages we will be passing through. I can’t say enough good things.

What The Climbers Are Saying

“What was completely unexpected on our Kilimanjaro trip was the level of camaraderie that immediately formed in the group – like-minded, interesting and interested, generous and unquitting”

Nina Kjellson, general partner, Canaan Partners

“The proposition: join Luke and equal numbers of men & women in our industry to raise money for cancer research at the Fred Hutch and climb Mt. Kilimanjaro. This was the experience of a lifetime. Breathtaking scenery – yes. Challenging physically – yes. Outstanding guides & support personnel – yes. Life-long bonding experiences – yes!”

Bill Newell, CEO, Sutro Biopharma

“Luke’s Climb to Fight Cancer trip to Kilimanjaro was simply the best chance ever to get to know a high quality group of biotech executives well. And so much more. Consider his future trips if you love the industry and hate cancer.”

Bob More, partner, Alta Partners